(Total Views: 424)
Posted On: 01/25/2021 3:20:49 PM
Post# of 58

$ABEO News Article - Abeona Therapeutics Announces Successful Type B Meeting with FDA for Pivotal Phase 3 VIITAL(TM) Study of EB-101 in Recessive Dystrophic Epidermolysis Bullosa (RDEB) https://marketwirenews.com/news-releases/abeo...46995.html


My Twitter: WhyteStocks